12:00 AM
 | 
May 07, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Lyrica pregabalin: Phase IIIb data

Top-line data from the double-blind, international Phase IIIb A0081242 trial in 294 patients with inadequately treated painful DPN showed that Lyrica missed the primary endpoint of improving mean pain score from baseline to week 19 vs. placebo (3.9 vs. 3.5 points, p-value not disclosed). In the single-blind portion of the trial, 665 patients received once-daily 150...

Read the full 256 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >